Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge

Leukemia. 2002 Sep;16(9):1884-6. doi: 10.1038/sj.leu.2402567.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Doxorubicin / therapeutic use*
  • Hepatitis / complications*
  • Hepatitis B virus / immunology*
  • Hepatitis B virus / pathogenicity
  • Humans
  • Lymphoma / complications
  • Lymphoma / therapy*
  • Lymphoma / virology*
  • Male
  • Middle Aged
  • Prednisone / therapeutic use*
  • Rituximab
  • Vincristine / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol